US Stock MarketDetailed Quotes

GMVDF G Medical Innovations

Watchlist
  • 0.009
  • 0.0000.00%
15min DelayClose Jul 22 09:30 ET
301.29KMarket Cap0.00P/E (TTM)

G Medical Innovations Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2022
(FY)Dec 31, 2021
(FY)Dec 31, 2020
(FY)Dec 31, 2019
(FY)Dec 31, 2018
Total revenue
-10.91%4.42M
1.24%4.96M
-11.33%4.9M
80.47%5.53M
3.06M
Operating revenue
-10.91%4.42M
1.24%4.96M
-11.33%4.9M
80.47%5.53M
--3.06M
Cost of revenue
5.33%3.64M
-18.45%3.45M
-26.37%4.23M
42.62%5.75M
4.03M
Gross profit
-48.05%784K
126.24%1.51M
399.10%667K
76.99%-223K
-969K
Operating expense
125.97%28.19M
-3.78%12.48M
3.27%12.97M
-22.57%12.56M
16.22M
Selling and administrative expenses
158.08%24.86M
23.51%9.63M
0.03%7.8M
-41.26%7.8M
--13.27M
-Selling and marketing expense
----
----
----
----
--664K
-General and administrative expense
158.08%24.86M
23.51%9.63M
0.03%7.8M
-38.17%7.8M
--12.61M
Research and development costs
36.43%2.29M
27.76%1.68M
-48.47%1.32M
950.21%2.55M
--243K
Depreciation amortization depletion
9.93%487K
-87.55%443K
85.99%3.56M
-26.76%1.91M
--2.61M
-Depreciation and amortization
9.93%487K
-87.55%443K
85.99%3.56M
-26.76%1.91M
--2.61M
Provision for doubtful accounts
-22.68%559K
144.26%723K
0.34%296K
--295K
----
Other operating expenses
----
----
----
----
--88K
Operating profit
-149.91%-27.41M
10.83%-10.97M
3.75%-12.3M
25.63%-12.78M
-17.18M
Net non-operating interest income expense
148.69%1.92M
-465.90%-3.93M
80.62%-695K
-2,518.25%-3.59M
-137K
Non-operating interest income
972.09%5.99M
916.36%559K
-79.09%55K
-69.35%263K
--858K
Non-operating interest expense
-9.22%4.08M
498.93%4.49M
-80.52%750K
286.93%3.85M
--995K
Other net income (expense)
3,614.79%11.55M
29.58%311K
240K
Gain on sale of security
3,614.79%11.55M
29.58%311K
--240K
----
----
Income before tax
4.44%-13.94M
-14.83%-14.59M
22.36%-12.71M
5.51%-16.37M
-17.32M
Income tax
633.33%16K
83.33%-3K
97.90%-18K
-148.41%-857K
-345K
Net income
-68.36%-25.07M
-17.34%-14.89M
18.19%-12.69M
8.64%-15.51M
-16.98M
Net income continuous Operations
4.31%-13.96M
-14.97%-14.59M
18.19%-12.69M
8.64%-15.51M
---16.98M
Net income discontinuous operations
-3,590.37%-11.11M
---301K
--0
----
----
Minority interest income
-236.15%-437K
14.47%-130K
-152K
Net income attributable to the parent company
-66.89%-24.63M
-17.72%-14.76M
19.17%-12.54M
8.64%-15.51M
-16.98M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-66.89%-24.63M
-17.72%-14.76M
19.17%-12.54M
8.64%-15.51M
-16.98M
Basic earnings per share
24.88%-34.17
23.76%-45.49
51.15%-59.67
-1,296.00%-122.15
-8.75
Diluted earnings per share
24.88%-34.17
23.76%-45.49
51.15%-59.67
-1,296.00%-122.15
-8.75
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
(FY)Dec 31, 2022(FY)Dec 31, 2021(FY)Dec 31, 2020(FY)Dec 31, 2019(FY)Dec 31, 2018
Total revenue -10.91%4.42M1.24%4.96M-11.33%4.9M80.47%5.53M3.06M
Operating revenue -10.91%4.42M1.24%4.96M-11.33%4.9M80.47%5.53M--3.06M
Cost of revenue 5.33%3.64M-18.45%3.45M-26.37%4.23M42.62%5.75M4.03M
Gross profit -48.05%784K126.24%1.51M399.10%667K76.99%-223K-969K
Operating expense 125.97%28.19M-3.78%12.48M3.27%12.97M-22.57%12.56M16.22M
Selling and administrative expenses 158.08%24.86M23.51%9.63M0.03%7.8M-41.26%7.8M--13.27M
-Selling and marketing expense ------------------664K
-General and administrative expense 158.08%24.86M23.51%9.63M0.03%7.8M-38.17%7.8M--12.61M
Research and development costs 36.43%2.29M27.76%1.68M-48.47%1.32M950.21%2.55M--243K
Depreciation amortization depletion 9.93%487K-87.55%443K85.99%3.56M-26.76%1.91M--2.61M
-Depreciation and amortization 9.93%487K-87.55%443K85.99%3.56M-26.76%1.91M--2.61M
Provision for doubtful accounts -22.68%559K144.26%723K0.34%296K--295K----
Other operating expenses ------------------88K
Operating profit -149.91%-27.41M10.83%-10.97M3.75%-12.3M25.63%-12.78M-17.18M
Net non-operating interest income expense 148.69%1.92M-465.90%-3.93M80.62%-695K-2,518.25%-3.59M-137K
Non-operating interest income 972.09%5.99M916.36%559K-79.09%55K-69.35%263K--858K
Non-operating interest expense -9.22%4.08M498.93%4.49M-80.52%750K286.93%3.85M--995K
Other net income (expense) 3,614.79%11.55M29.58%311K240K
Gain on sale of security 3,614.79%11.55M29.58%311K--240K--------
Income before tax 4.44%-13.94M-14.83%-14.59M22.36%-12.71M5.51%-16.37M-17.32M
Income tax 633.33%16K83.33%-3K97.90%-18K-148.41%-857K-345K
Net income -68.36%-25.07M-17.34%-14.89M18.19%-12.69M8.64%-15.51M-16.98M
Net income continuous Operations 4.31%-13.96M-14.97%-14.59M18.19%-12.69M8.64%-15.51M---16.98M
Net income discontinuous operations -3,590.37%-11.11M---301K--0--------
Minority interest income -236.15%-437K14.47%-130K-152K
Net income attributable to the parent company -66.89%-24.63M-17.72%-14.76M19.17%-12.54M8.64%-15.51M-16.98M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -66.89%-24.63M-17.72%-14.76M19.17%-12.54M8.64%-15.51M-16.98M
Basic earnings per share 24.88%-34.1723.76%-45.4951.15%-59.67-1,296.00%-122.15-8.75
Diluted earnings per share 24.88%-34.1723.76%-45.4951.15%-59.67-1,296.00%-122.15-8.75
Dividend per share
Currency Unit USDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg